228 related articles for article (PubMed ID: 29618121)
1. Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis.
Miyagawa I; Nakayamada S; Nakano K; Kubo S; Iwata S; Miyazaki Y; Yoshikawa M; Yoshinari H; Tanaka Y
Rheumatology (Oxford); 2019 Feb; 58(2):336-344. PubMed ID: 29618121
[TBL] [Abstract][Full Text] [Related]
2. Psoriatic arthritis in Japan: difference in clinical features and approach to precision medicine.
Tanaka Y
Clin Exp Rheumatol; 2016; 34(4 Suppl 98):49-52. PubMed ID: 27586804
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis.
Nakayamada S; Kubo S; Yoshikawa M; Miyazaki Y; Yunoue N; Iwata S; Miyagawa I; Hirata S; Nakano K; Saito K; Tanaka Y
Rheumatology (Oxford); 2018 Jan; 57(1):164-174. PubMed ID: 28371836
[TBL] [Abstract][Full Text] [Related]
4. Precision medicine based on the phenotypic differences in peripheral T helper cells in patients with psoriatic arthritis: One year follow-up outcomes.
Miyagawa I; Nakayamada S; Ueno M; Miyazaki Y; Ohkubo N; Inoue Y; Kubo S; Tanaka Y
Front Med (Lausanne); 2022; 9():934937. PubMed ID: 35966881
[TBL] [Abstract][Full Text] [Related]
5. Switching biologics in the treatment of psoriatic arthritis.
Merola JF; Lockshin B; Mody EA
Semin Arthritis Rheum; 2017 Aug; 47(1):29-37. PubMed ID: 28363434
[TBL] [Abstract][Full Text] [Related]
6. Circulating T helper and T regulatory subsets in untreated early rheumatoid arthritis and healthy control subjects.
Pandya JM; Lundell AC; Hallström M; Andersson K; Nordström I; Rudin A
J Leukoc Biol; 2016 Oct; 100(4):823-833. PubMed ID: 27190305
[TBL] [Abstract][Full Text] [Related]
7. Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset.
Gutiérrez-Bautista JF; Rodriguez-Nicolas A; Rosales-Castillo A; Jiménez P; Garrido F; Anderson P; Ruiz-Cabello F; López-Ruz MÁ
Front Immunol; 2020; 11():596553. PubMed ID: 33324414
[TBL] [Abstract][Full Text] [Related]
8. The approach to precision medicine for the treatment of psoriatic arthritis.
Miyagawa I; Tanaka Y
Immunol Med; 2020 Sep; 43(3):98-102. PubMed ID: 32306849
[TBL] [Abstract][Full Text] [Related]
9. Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients.
Simon D; Kleyer A; Bayat S; Tascilar K; Kampylafka E; Meinderink T; Schuster L; Petrov R; Liphardt AM; Rech J; Schett G; Hueber AJ
Arthritis Res Ther; 2019 Jul; 21(1):162. PubMed ID: 31269973
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of minimal disease activity in Australian patients with Psoriatic Arthritis: Assessing the outcome of national funding criteria for biologic disease-modifying antirheumatic drug prescribing.
Pontifex EK; Dissanayake K; Bursill D; Gill T
Int J Rheum Dis; 2019 Feb; 22(2):262-268. PubMed ID: 30450819
[TBL] [Abstract][Full Text] [Related]
11. Ustekinumab for the treatment of psoriasis and psoriatic arthritis: a drug evaluation and literature review.
Thibodaux RJ; Triche MW; Espinoza LR
Expert Opin Biol Ther; 2018 Jul; 18(7):821-827. PubMed ID: 29949399
[TBL] [Abstract][Full Text] [Related]
12. Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis.
Miao J; Zhang K; Lv M; Li Q; Zheng Z; Han Q; Guo N; Fan C; Zhu P
Scand J Rheumatol; 2014; 43(3):194-201. PubMed ID: 24392804
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of abatacept, apremilast, secukinumab and ustekinumab treatment of psoriatic arthritis: a systematic review and network meta-analysis.
Kawalec P; Holko P; Moćko P; Pilc A
Rheumatol Int; 2018 Feb; 38(2):189-201. PubMed ID: 29285605
[TBL] [Abstract][Full Text] [Related]
14. T-helper 17 cells: the driving force of psoriasis and psoriatic arthritis.
Yoo IS; Lee JH; Song ST; Kim JH; Lee HJ; Kang SW
Int J Rheum Dis; 2012 Dec; 15(6):531-7. PubMed ID: 23253236
[TBL] [Abstract][Full Text] [Related]
15. IL-10 producing Bregs are impaired in psoriatic arthritis and psoriasis and inversely correlate with IL-17- and IFNγ-producing T cells.
Mavropoulos A; Varna A; Zafiriou E; Liaskos C; Alexiou I; Roussaki-Schulze A; Vlychou M; Katsiari C; Bogdanos DP; Sakkas LI
Clin Immunol; 2017 Nov; 184():33-41. PubMed ID: 28461105
[TBL] [Abstract][Full Text] [Related]
16. Optimising psoriatic arthritis therapy with immunological methods to increase standard evaluation: the protocol of an open-label multicentre, parallel-group, two-arm randomised controlled study evaluation precision medicine approach in the treatment of psoriatic arthritis.
Ooms A; Al-Mossawi H; Bennett L; Bogale M; Bowness P; Francis A; Goodyear C; Kirkham BW; Lalnunhlimi S; McInnes IB; Richards D; Siebert S; Taams LS; Tulunay Virlan A; Yager N; Coates LC
BMJ Open; 2023 Sep; 13(9):e078539. PubMed ID: 37770264
[TBL] [Abstract][Full Text] [Related]
17. Increased peripheral helper T cells type 17 subset correlates with the severity of psoriasis vulgaris.
Liu W; Zhou X; Wang A; Ma J; Bai Y
Immunol Lett; 2021 Jan; 229():48-54. PubMed ID: 33232721
[TBL] [Abstract][Full Text] [Related]
18. Is precision medicine possible in rheumatic diseases? Lessons from selective use of targeted therapies in patients with psoriatic arthritis.
Miyagawa I; Tanaka Y
Expert Rev Clin Immunol; 2020 Feb; 16(2):199-206. PubMed ID: 31905298
[No Abstract] [Full Text] [Related]
19. Effect of methotrexate monotherapy on T-cell subsets in the peripheral circulation in psoriasis.
Priyadarssini M; Chandrashekar L; Rajappa M
Clin Exp Dermatol; 2019 Jul; 44(5):491-497. PubMed ID: 30294828
[TBL] [Abstract][Full Text] [Related]
20. Decreased Th17 and Th1 cells in the peripheral blood of patients with early non-radiographic axial spondyloarthritis: a marker of disease activity in HLA-B27⁺ patients.
Bautista-Caro MB; Arroyo-Villa I; Castillo-Gallego C; de Miguel E; Peiteado D; Puig-Kröger A; Martín-Mola E; Miranda-Carús ME
Rheumatology (Oxford); 2013 Feb; 52(2):352-62. PubMed ID: 23065314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
